NO20076245L - Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner - Google Patents

Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner

Info

Publication number
NO20076245L
NO20076245L NO20076245A NO20076245A NO20076245L NO 20076245 L NO20076245 L NO 20076245L NO 20076245 A NO20076245 A NO 20076245A NO 20076245 A NO20076245 A NO 20076245A NO 20076245 L NO20076245 L NO 20076245L
Authority
NO
Norway
Prior art keywords
tfpi
bacterial infections
treat severe
risk
severe bacterial
Prior art date
Application number
NO20076245A
Other languages
English (en)
Norwegian (no)
Inventor
Stephen F Hardy
Yumin Dai
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20076245L publication Critical patent/NO20076245L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
NO20076245A 2005-05-06 2007-12-04 Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner NO20076245L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67846505P 2005-05-06 2005-05-06
PCT/US2006/017956 WO2006122139A2 (fr) 2005-05-06 2006-05-08 Utilisation de tfpi dans le traitement d'infections bacteriennes aigues

Publications (1)

Publication Number Publication Date
NO20076245L true NO20076245L (no) 2007-12-06

Family

ID=37103012

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076245A NO20076245L (no) 2005-05-06 2007-12-04 Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner

Country Status (16)

Country Link
US (1) US20090214506A1 (fr)
EP (1) EP1877081A2 (fr)
JP (1) JP2008540460A (fr)
KR (1) KR20080017021A (fr)
CN (1) CN101400365A (fr)
AU (1) AU2006244053A1 (fr)
BR (1) BRPI0611049A2 (fr)
CA (1) CA2607293A1 (fr)
IL (1) IL187111A0 (fr)
MA (1) MA29489B1 (fr)
MX (1) MX2007013876A (fr)
NO (1) NO20076245L (fr)
RU (1) RU2007145202A (fr)
TN (1) TNSN07413A1 (fr)
WO (1) WO2006122139A2 (fr)
ZA (1) ZA200709520B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124355A1 (en) 2006-09-22 2008-05-29 David Gordon Bermudes Live bacterial vaccines for viral infection prophylaxis or treatment
WO2009129164A1 (fr) * 2008-04-15 2009-10-22 Novartis Ag Combinaisons pharmaceutiques de fragments de tfpi et d'un antibiotique
US8241623B1 (en) 2009-02-09 2012-08-14 David Bermudes Protease sensitivity expression system
GB0916578D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US9597379B1 (en) 2010-02-09 2017-03-21 David Gordon Bermudes Protease inhibitor combination with therapeutic proteins including antibodies
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
US9593339B1 (en) 2013-02-14 2017-03-14 David Gordon Bermudes Bacteria carrying bacteriophage and protease inhibitors for the treatment of disorders and methods of treatment
EP3022228B1 (fr) 2013-07-19 2019-02-27 Novo Nordisk A/S Anticorps capables de se lier spécifiquement à la partie n-terminale de l'inhibiteur de la voie du facteur tissulaire (tfpi (1-79))
CN105777875B (zh) * 2016-05-26 2020-02-11 青岛农业大学 一种抗菌肽cstc24及其应用
CN105777876B (zh) * 2016-05-26 2020-02-11 青岛农业大学 一种抗菌肽tc38及其应用
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11572295B1 (en) * 2019-06-11 2023-02-07 Swamp Fox Innovations, LLC Compositions and methods for reduction of free chlorine and related odor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200400549A1 (ru) * 2001-10-15 2005-02-24 Чирон Корпорейшн Лечение сепсиса введением малых доз ингибитора пути тканевого фактора (tfpi)
EP1654283B1 (fr) * 2003-08-13 2011-07-13 Novartis Vaccines and Diagnostics, Inc. Procede ameliore de purification d'analogues tfpi et tfpi

Also Published As

Publication number Publication date
CA2607293A1 (fr) 2006-11-16
BRPI0611049A2 (pt) 2010-08-10
WO2006122139A2 (fr) 2006-11-16
AU2006244053A1 (en) 2006-11-16
MX2007013876A (es) 2008-04-02
MA29489B1 (fr) 2008-05-02
ZA200709520B (en) 2008-11-26
EP1877081A2 (fr) 2008-01-16
TNSN07413A1 (en) 2009-03-17
RU2007145202A (ru) 2009-06-20
US20090214506A1 (en) 2009-08-27
JP2008540460A (ja) 2008-11-20
WO2006122139A3 (fr) 2007-04-26
IL187111A0 (en) 2008-02-09
CN101400365A (zh) 2009-04-01
KR20080017021A (ko) 2008-02-25

Similar Documents

Publication Publication Date Title
NO20076245L (no) Anvendelse av TFPI for a behandle alvorlige bakterieinfeksjoner
WO2007143600A3 (fr) Inhibiteurs de la sheddase combinés avec des substances immunothérapeutiques se liant à cd30 destinés au traitement de maladies associées à cd30
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
WO2009039397A3 (fr) Amides substitués, procédé pour les préparer et procédé pour les utiliser
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
WO2009021521A3 (fr) Procédé de traitement d'une dépression médiée par un stress
HK1120409A1 (en) Treatment of diseases by subcutaneous administration of a vegf antagonist
WO2006037031A3 (fr) Formulations et procedes destines au traitement de maladies inflammatoires
EA200971053A1 (ru) Способы лечения кожных язв
BR0111591A (pt) Compostos, composição farmacêutica, e, métodos para elevar o nìvel de plasma do hormÈnio de crescimento em um mamìfero, para o tratamento de deficiência da secreção do hormÈnio de crescimento, para o tratamento do retardo do crescimento em crianças, para o tratamento de distúrbios metabólicos associados com a deficiência da secreção do hormÈnio de crescimento, em particular em pacientes idosos, e para promover a cura de ferimentos, recupeção de cirurgia ou recuperação de doenças debilitantes
NO20064964L (no) Behandling av svekket respiratorisk funksjon
WO2003032904A3 (fr) Traitement de la pneumonie grave par administration d'un inhibiteur du mecanisme d'action du facteur tissulaire (tfpi)
AU2012286851A8 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
WO2005087210A3 (fr) Prevention de la retinopathie par inhibition du cycle visuel
WO2007023072A3 (fr) Utilisation d'ambroxol pour traiter les infections a rhinovirus
WO2007081486A3 (fr) Administration orale de defensines pour traiter des maladies intestinales
RU2007112409A (ru) Одновременный прием тигициклина и дигоксина
KR20120128644A (ko) 질환의 치료에 사용하기 위한 화합물
NO20064674L (no) Behandling av alvorlig lungebetennelse ervervet utenfor sykehus ved administrering av vevsfaktor pathway inhibitor
EA201590825A1 (ru) Способы контролирования кровяного давления и снижения диспноэ при сердечной недостаточности
EA201000739A1 (ru) Новое медицинское применение солей 3-(2,2,2-триметилгидразиниум)пропионата
WO2010045416A3 (fr) Polytherapies pour le traitement de l'obesite
NO20075898L (no) Behandling av samfunnsvervet lungebetennelse ved administrering av vevsfaktor pathway inhibitor (TFPI)
TNSN07386A1 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)
WO2010045529A3 (fr) Thérapies de combinaison pour le traitement de l'obésité

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application